Anzeige
Considered the power generators of the cell, mitochondria convert oxygen and nutrients into chemical energy for the cell that fuels metabolic activities.
Mitochondrial dysfunction has been associated with many diseases, including Alzheimer's, cancer and diabetes, although its exact role in the development of these diseases remains controversial.
The new T-R01 program was specifically created under the NIH Roadmap for Medical Research to support exceptionally innovative, high risk, original or unconventional research projects that have the potential to transform a field of science. The selected projects tend to be inherently risky, but if successful, can profoundly impact a broad area of biomedical research.
Cohen’s bold proposal will test the paradigm-shifting hypothesis that previously unrecognized molecules, he dubbed “mitochondrial-derived peptides” (MDPs), play an earlier unappreciated role in the regulation of cellular and organismal function, and that disregulation of MDPs is important in disease development.
Likewise, understanding the role of MDPs may lead to development of new therapeutic and diagnostic targets. Since Alzheimer’s, cancer and diabetes particularly affect the elderly, these findings could have a significant impact as the world’s aging population continues to grow. The first of these agents, which Cohen named “small humanin-like peptides,” have already demonstrated promise in animal models of diabetes and cancer.
Cohen was one of only 42 researchers nationwide chosen for the T-R01 award. He also serves as chief of endocrinology at the Mattel Children's Hospital UCLA, as well as co-director of the UCSD/UCLA Diabetes and Endocrinology Research Center.
For more information on Cohen, research plans please visit http://nihroadmap.nih.gov/T-R01/Recipients09.asp
Amy Albin | Source: Newswise Science News
Further information: www.ucla.edu
nihroadmap.nih.gov/T-R01/Recipients09.asp
Further Reports about: Cancer > Diabetes > Endocrinologist > endocrinology > MDPs > mitochondrial-derived peptides > NIH > small humanin-like peptides > T-R01 > UCLA > unrecognized molecules
More articles from Awards Funding:
Call for Entries: Public Asked to Submit Videos to 2010 Neuro Film Festival
19.11.2009 | American Academy of Neurology
UT Southwestern Receives $42 Million in Recovery Act Stimulus Funding
16.11.2009 | UT Southwestern Medical Center
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News